Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has been given an average rating of “Moderate Buy” by the fourteen brokerages that are covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $16.77.
IAS has been the subject of several research reports. Oppenheimer reduced their price objective on Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, February 28th. Raymond James reduced their price objective on Integral Ad Science from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Friday, May 10th. Loop Capital initiated coverage on Integral Ad Science in a research report on Tuesday, April 30th. They issued a “buy” rating and a $15.00 price objective for the company. Barclays reduced their price objective on Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research report on Monday, April 15th. Finally, Craig Hallum cut their target price on Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, May 10th.
Get Our Latest Research Report on IAS
Integral Ad Science Stock Up 0.4 %
Integral Ad Science (NASDAQ:IAS – Get Free Report) last announced its earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $114.50 million during the quarter, compared to analysts’ expectations of $112.12 million. Integral Ad Science had a return on equity of 0.32% and a net margin of 0.59%. The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.02 earnings per share. Equities analysts expect that Integral Ad Science will post 0.22 earnings per share for the current year.
Insider Buying and Selling at Integral Ad Science
In related news, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total value of $25,379.28. Following the completion of the transaction, the chief accounting officer now directly owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Tania Secor sold 17,999 shares of Integral Ad Science stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $180,889.95. Following the completion of the sale, the chief financial officer now directly owns 239,174 shares in the company, valued at $2,403,698.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total value of $25,379.28. Following the completion of the sale, the chief accounting officer now owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 59,242 shares of company stock valued at $592,058. 2.00% of the stock is currently owned by company insiders.
Institutional Trading of Integral Ad Science
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Integral Ad Science during the 3rd quarter worth about $58,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Integral Ad Science during the 3rd quarter worth about $62,000. Ameritas Investment Partners Inc. grew its position in shares of Integral Ad Science by 40.1% during the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after buying an additional 1,924 shares during the period. Amalgamated Bank grew its position in shares of Integral Ad Science by 19.9% during the 3rd quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock worth $83,000 after buying an additional 1,156 shares during the period. Finally, Sherbrooke Park Advisers LLC acquired a new position in shares of Integral Ad Science during the 3rd quarter worth about $140,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories
- Five stocks we like better than Integral Ad Science
- What Is WallStreetBets and What Stocks Are They Targeting?
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Investing in the High PE Growth Stocks
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Overbought Stocks Explained: Should You Trade Them?
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.